Cargando…

HNPCC: Six new pathogenic mutations

BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disease with a high risk for colorectal and endometrial cancer caused by germline mutations in DNA mismatch-repair genes (MMR). HNPCC accounts for approximately 2 to 5% of all colorectal cancers. Here we present...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunstmann, Erdmute, Vieland, Judith, Brasch, Frank E, Hahn, Stephan A, Epplen, Joerg T, Schulmann, Karsten, Schmiegel, Wolff
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC446196/
https://www.ncbi.nlm.nih.gov/pubmed/15217520
http://dx.doi.org/10.1186/1471-2350-5-16
_version_ 1782121560766676992
author Kunstmann, Erdmute
Vieland, Judith
Brasch, Frank E
Hahn, Stephan A
Epplen, Joerg T
Schulmann, Karsten
Schmiegel, Wolff
author_facet Kunstmann, Erdmute
Vieland, Judith
Brasch, Frank E
Hahn, Stephan A
Epplen, Joerg T
Schulmann, Karsten
Schmiegel, Wolff
author_sort Kunstmann, Erdmute
collection PubMed
description BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disease with a high risk for colorectal and endometrial cancer caused by germline mutations in DNA mismatch-repair genes (MMR). HNPCC accounts for approximately 2 to 5% of all colorectal cancers. Here we present 6 novel mutations in the DNA mismatch-repair genes MLH1, MSH2 and MSH6. METHODS: Patients with clinical diagnosis of HNPCC were counselled. Tumor specimen were analysed for microsatellite instability and immunohistochemistry for MLH1, MSH2 and MSH6 protein was performed. If one of these proteins was not detectable in the tumor mutation analysis of the corresponding gene was carried out. RESULTS: We identified 6 frameshift mutations (2 in MLH1, 3 in MSH2, 1 in MSH6) resulting in a premature stop: two mutations in MLH1 (c.2198_2199insAACA [p.N733fsX745], c.2076_2077delTG [p.G693fsX702]), three mutations in MSH2 (c.810_811delGT [p.C271fsX282], c.763_766delAGTGinsTT [p.F255fsX282], c.873_876delGACT [p.L292fsX298]) and one mutation in MSH6 (c.1421_1422dupTG [p.C475fsX480]). All six tumors tested for microsatellite instability showed high levels of microsatellite instability (MSI-H). CONCLUSIONS: HNPCC in families with MSH6 germline mutations may show an age of onset that is comparable to this of patients with MLH1 and MSH2 mutations.
format Text
id pubmed-446196
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-4461962004-07-09 HNPCC: Six new pathogenic mutations Kunstmann, Erdmute Vieland, Judith Brasch, Frank E Hahn, Stephan A Epplen, Joerg T Schulmann, Karsten Schmiegel, Wolff BMC Med Genet Research Article BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disease with a high risk for colorectal and endometrial cancer caused by germline mutations in DNA mismatch-repair genes (MMR). HNPCC accounts for approximately 2 to 5% of all colorectal cancers. Here we present 6 novel mutations in the DNA mismatch-repair genes MLH1, MSH2 and MSH6. METHODS: Patients with clinical diagnosis of HNPCC were counselled. Tumor specimen were analysed for microsatellite instability and immunohistochemistry for MLH1, MSH2 and MSH6 protein was performed. If one of these proteins was not detectable in the tumor mutation analysis of the corresponding gene was carried out. RESULTS: We identified 6 frameshift mutations (2 in MLH1, 3 in MSH2, 1 in MSH6) resulting in a premature stop: two mutations in MLH1 (c.2198_2199insAACA [p.N733fsX745], c.2076_2077delTG [p.G693fsX702]), three mutations in MSH2 (c.810_811delGT [p.C271fsX282], c.763_766delAGTGinsTT [p.F255fsX282], c.873_876delGACT [p.L292fsX298]) and one mutation in MSH6 (c.1421_1422dupTG [p.C475fsX480]). All six tumors tested for microsatellite instability showed high levels of microsatellite instability (MSI-H). CONCLUSIONS: HNPCC in families with MSH6 germline mutations may show an age of onset that is comparable to this of patients with MLH1 and MSH2 mutations. BioMed Central 2004-06-24 /pmc/articles/PMC446196/ /pubmed/15217520 http://dx.doi.org/10.1186/1471-2350-5-16 Text en Copyright © 2004 Kunstmann et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Kunstmann, Erdmute
Vieland, Judith
Brasch, Frank E
Hahn, Stephan A
Epplen, Joerg T
Schulmann, Karsten
Schmiegel, Wolff
HNPCC: Six new pathogenic mutations
title HNPCC: Six new pathogenic mutations
title_full HNPCC: Six new pathogenic mutations
title_fullStr HNPCC: Six new pathogenic mutations
title_full_unstemmed HNPCC: Six new pathogenic mutations
title_short HNPCC: Six new pathogenic mutations
title_sort hnpcc: six new pathogenic mutations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC446196/
https://www.ncbi.nlm.nih.gov/pubmed/15217520
http://dx.doi.org/10.1186/1471-2350-5-16
work_keys_str_mv AT kunstmannerdmute hnpccsixnewpathogenicmutations
AT vielandjudith hnpccsixnewpathogenicmutations
AT braschfranke hnpccsixnewpathogenicmutations
AT hahnstephana hnpccsixnewpathogenicmutations
AT epplenjoergt hnpccsixnewpathogenicmutations
AT schulmannkarsten hnpccsixnewpathogenicmutations
AT schmiegelwolff hnpccsixnewpathogenicmutations